Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Chi, K. N
8792  Ergebnisse:
Personensuche X
?
1

Niraparib plus abiraterone acetate with prednisone in patie..:

Chi, K.N. ; Sandhu, S. ; Smith, M.R....
Annals of Oncology.  34 (2023)  9 - p. 772-782 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Deep, rapid, and durable prostate-specific antigen decline ..:

Chowdhury, S. ; Bjartell, A. ; Agarwal, N....
Annals of Oncology.  34 (2023)  5 - p. 477-485 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Résultats de qualité de vie liée à la santé, douleur et tol..:

Fizazi, K. ; Flippot, R. ; Hermann, K....
Médecine Nucléaire.  46 (2022)  2 - p. 51 , 2022
Link: https://doi.org/10.1016/..
 
?
4

PSMAfore : essai de phase 3 comparant le 177Lu-PSMA-617 ver..:

Fizazi, K. ; Flippot, R. ; Sartor, O....
Médecine Nucléaire.  46 (2022)  2 - p. 76-77 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Étude de phase 3 du 177Lu-PSMA-617 dans le traitement des p..:

Fizazi, K. ; Flippot, R. ; Morris, M.J....
Médecine Nucléaire.  46 (2022)  2 - p. 50-51 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Exploratory analyses of incidence of skin rash and efficacy..:

Azad, A.A. ; Chua, M.L.K. ; Smith, M.R....
European Urology Open Science.  33 (2021)  - p. S286-S287 , 2021
Link: https://doi.org/10.1016/..
 
?
7

Apalutamide (apa) for metastatic castration-sensitive prost..:

Chowdhury, S. ; Bjartell, A. ; Merseburger, A.S....
European Urology.  79 (2021)  - p. S1180-S1181 , 2021
Link: https://doi.org/10.1016/..
 
?
8

Carbon-encapsulated MnFe2O4 nanoparticles: effects of carbo..:

Tuyen, T. V. ; Chi, N. K. ; Tien, D. T....
Applied Physics A.  126 (2020)  7 - p. , 2020
Link: https://doi.org/10.1007/..
 
?
9

Apalutamide (APA) for metastatic castration-sensitive prost..:

Bjartell, A.S. ; Ye, D. ; Agarwal, N....
European Urology Open Science.  19 (2020)  - p. e863-e864 , 2020
Link: https://doi.org/10.1016/..
 
?
10

Second-Line Systemic Therapies for Metastatic Urothelial Ca..:

Tsang, E.S. ; Forbes, C. ; Chi, K. N...
Current Oncology.  26 (2019)  2 - p. 260-265 , 2019
Link: https://doi.org/10.3747/..
 
?
11

Patient-reported outcomes (PROs) From TITAN: A phase 3, ran..:

Agarwal, N. ; Mcquarrie, K. ; Bjartell, A....
European Urology Supplements.  18 (2019)  11 - p. e3413-e3414 , 2019
Link: https://doi.org/10.1016/..
 
?
12

A prognostic index model for predicting overall survival in..:

Chi, K.N. ; Kheoh, T. ; Ryan, C.J....
Annals of Oncology.  27 (2016)  3 - p. 454-460 , 2016
Link: https://doi.org/10.1093/..
 
?
13

Denosumab for the prevention of skeletal complications in m..:

Smith, M.R. ; Coleman, R.E. ; Klotz, L....
Annals of Oncology.  26 (2015)  2 - p. 368-374 , 2015
Link: https://doi.org/10.1093/..
 
?
14

A phase II study of the HDAC inhibitor SB939 in patients wi..:

Eigl, B. J. ; North, S. ; Winquist, E....
Investigational New Drugs.  33 (2015)  4 - p. 969-976 , 2015
Link: https://doi.org/10.1007/..
 
?
15

2508 Three-arm phase II randomized trial of docetaxel monot..:

Petrylak, D.P. ; Tagawa, S.T. ; Kohli, M....
European Journal of Cancer.  51 (2015)  - p. S476 , 2015
Link: https://doi.org/10.1016/..
 
1-15